mTOR-inhibitors and post-transplant diabetes mellitus: a link still debated in kidney transplantation

The mammalian target of rapamycin inhibitors (mTOR-Is, Sirolimus, and Everolimus) are immunosuppressive drugs widely employed in kidney transplantation. Their main mechanism of action includes the inhibition of a serine/threonine kinase with a pivotal role in cellular metabolism and in various eukar...

Descripción completa

Detalles Bibliográficos
Autores principales: Granata, Simona, Mercuri, Silvia, Troise, Dario, Gesualdo, Loreto, Stallone, Giovanni, Zaza, Gianluigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213242/
https://www.ncbi.nlm.nih.gov/pubmed/37250653
http://dx.doi.org/10.3389/fmed.2023.1168967

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213242/
https://www.ncbi.nlm.nih.gov/pubmed/37250653
http://dx.doi.org/10.3389/fmed.2023.1168967

Ejemplares similares